Office of Research & Development |
![]() ![]() |
Project Number: | I01BX004589-01 |
Title: | Pharmacological and toxicological testing of a novel L-asparaginase |
Principal Investigator: | Arnon Lavie |
Location: | Chicago, IL |
Congressional District Code: | 7 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | April 2019 - March 2023 |
FY 2021 Funding Amount: | $260,845 |
Total Award Amount (all years): |
$1,263,493 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Project Summary: The goal of this proposal is to perform IND-enabling studies of a significantly safer variant of the anti-cancer biologic drug L-asparaginase. L-asparaginases are enzyme drugs that act to deplete the amino acid asparagine from the blood. Due to toxicity, which is especially pronounced in adults, L- asparaginase treatment is limited to acute lymphoblastic leukemia (ALL), a cancer of white blood cells. One source of toxicity of L-asparaginases is due to their bacterial origin (eit... |